Excited to share that I was awarded a top undergraduate poster at Brown’s Public Health Research Day 2024!

Thank you to Ashish K. Jha, MD, MPH and Brown University School of Public Health for the honor.

Special thank you to David Meyers and Amal Trivedi for their, continued support, guidance, and mentorship!

We also found limited evidence that benchmark changes (induced by quartile payment system) affected plan offerings or enrollment: jamanetwork.com/journals/jama-…

I’m in today’s New York Times! Honored to have been selected as a PD Soros Fellowships Fellow out of the nearly 2,400 applicants. I’ve had the pleasure of having incredible help from so many people and there’s some specific people I would like to thank 1/4

Brown’s HSR PhD was my dream program because of the opportunity to get to work with David Meyers and Andrew Ryan. Working with them has only exceeded my expectations. They’re incredible mentors and this fellowship selection wouldn’t have happened without their support 3/4

Looks like a great paper on a highly relevant topic

RE 'Also agree there is no way ACOs are responsible for the slowdown in per-bene spending following the ACA – I do not view that as a serious take'

That ACOs/VBP are responsible for slowdown is a common take: statnews.com/2023/12/21/hea…

This is fair enough, but there is an opportunity cost. In the 10 years post ACA, CMS was focused implementing ACOs and other parts of the value strategy (e.g. MIPS). Researchers focused on evaluation. MA grew with relatively little scrutiny from policy community at this time.

Agree that squeezing physician payment forever is not the path to long term Medicare sustainability. Most important issue is use of new tech. MA adoption of biosimilars is an example of how incentives can lead to lower cost substitution.

We estimated savings in the MSSP using your treatment effect from the NEJM paper. Gross savings exceeded incentive payments through 2018. This changed 2019, leading to net losses over the life of the program.

Price caps can work! Andrew Ryan and I discuss Oregon’s success in an opinion piece in STAT. Check it out 👇

A strategy is spreading in Medicare Advantage — insurers are increasingly advertising specific plans to specific people based on identity.

We explore these emerging Medicare Advantage “Affinity Plans” in a new viewpoint.

jamanetwork.com/journals/jama/… /1

In their new Forefront article David Meyers, Andrew Ryan, Jared Perkins + Erin Fuse Brown of Brown University School of Public Health + Georgia State University argue that changes to risk adjustment are a step in the right direction, but there are other ways to get differential coding under control. bit.ly/3TQnhqx

In this article, we describe some of the high level proposed changes in this year's Medicare Advantage Advance Notice- tldr, not much to see but a couple steps in the right direction, with plenty more that can be done. Looking forward to seeing the final rule in a few weeks!